Aggressiveness - OmicsDI

Show results for

Unknown (5372)
Genomics (926)
Transcriptomics (728)
Proteomics (141)
Methylation profiling (33)
Other (15)
Metabolomics (10)
Clinical (6)
Genomic (2)
Models (1)

Organisms

Homo sapiens (730)
Mus musculus (160)
Aerococcus urinae NBRC 15544 = CCUG 36881 (119)
Rattus norvegicus (7)
synthetic construct (6)
Sus scrofa (4)
Phytophthora infestans (4)
Arabidopsis thaliana (3)
Drosophila melanogaster (3)
Glycine max (2)
Equus caballus (2)
Fusarium graminearum (2)
Canis lupus familiaris (2)
Danio rerio (2)
Sus scrofa domesticus (1)
Hordeum vulgare (1)
Phelipanche ramosa (1)
Phaeosphaeria sp. MPI-PUGE-AT-0046c (1)
Chaetomium sp. MPI-CAGE-AT-0009 (1)
Truncatella angustata (1)
Paraphoma chrysanthemicola (1)
Chaetomium sp. (1)
Halenospora varia (1)
Phaeosphaeria sp. (1)
Macrophomina phaseolina (1)
Penicillium polonicum (1)
Penicillium expansum (1)
Felis catus (1)
Gasterosteus aculeatus (1)
Mus (1)

Organisms

Homo sapiens (510)
Mus musculus (117)
Phytophthora infestans (4)
Rattus norvegicus (3)
Betta splendens (2)
Sus scrofa domesticus (2)
Gasterosteus aculeatus (2)
Drosophila melanogaster (2)
Equus caballus (2)
Canis lupus familiaris (2)
Sus scrofa (2)
Danio rerio (2)
Ursus arctos arctos (1)
Phelipanche ramosa (1)
Melampsora laricis-populina (1)
Pinus nigra (1)
Colletotrichum (1)
Sclerotinia sclerotiorum (1)
Fusarium graminearum (1)
Pyricularia oryzae (1)
Mus (1)
Glycine max (1)
Felis catus (1)
Ursus arctos (1)
Zea mays (1)

Repository

ENA (800)
geo (669)
biostudies-arrayexpress (209)
pride (119)
EGA (22)
iProX (10)
MassIVE (10)
MetaboLights (10)
ExpressionAtlas (2)
dbGaP (2)
BioModels (1)
GPMDB (1)
jPOST (1)

Tissue

Cell culture (35)
Brain (12)
Epithelial cell (10)
Melanocyte (6)
Lung (5)
Pleural mesothelium (5)
Hepatocyte (4)
Liver (4)
Prostate gland (4)
Fibroblast (3)
Mesothelial fibroblast (3)
Blood plasma (2)
Breast (2)
Fibroblast of lung (2)
Kidney (2)
Malignant cell (2)
Mesothelial cell of pleura (2)
Neoplastic cell (2)
Neuroblastoma cell line (2)
Permanent cell line cell (2)
Primary cell (2)
Spikelet (2)
Subcutaneous preadipocyte (2)
Urinary bladder (2)
Urine (2)
Adipocyte (1)
Adipose tissue (1)
B cell (1)
Bladder (1)
CCD-18Co cell (1)

Disease

Breast cancer (11)
Brain cancer (8)
Brain glioblastoma multiforme (5)
Glioblastoma (5)
Neuroblastoma (4)
Colorectal Neoplasms (4)
Prostate cancer (4)
Alzheimer's disease (3)
Malignant pleural mesothelioma (3)
Melanoma (3)
Prostate adenocarcinoma (3)
Urinary bladder cancer (3)
Normal (2)
Acute leukemia (2)
Liver cancer (2)
Medulloblastoma (2)
Pancreatic cancer (2)
Pancreatic ductal adenocarcinoma (2)
Locally advanced breast carcinoma (LABC; non-inflammatory) (1)
Benign meningioma (1)
Alveolar rhabdomyosarcoma (1)
2h after infection with wildtype Streptococcus pyogenes (1)
None (1)
Neoplasm Micrometastasis (1)
Neoplasm Metastasis (1)
Not Available (1)
Acute myeloid leukemia (1)
Carcinoma (1)
Cervix carcinoma (1)
Chronic lymphocytic leukemia (1)

Technology Type

Mass Spectrometry (119)
Shotgun proteomics (73)
Bottom-up proteomics (24)
Affinity purification coupled with mass spectrometry proteomics (10)
Data-dependent acquisition (10)
SWATH MS (10)
Gel-based experiment (8)
Mass spectrometry assay (7)
Data-independent acquisition (7)
DiaPASEF (4)
Mass spectrometry (3)
Illumina HiSeq 2000, ILLUMINA (2)
SRM/MRM (2)
ILLUMINA, Affymetrix HG_U133_+2, HUMANOMNIEXPRESS, Illumina HiSeq 2000 (1)
Affymetrix OncoScan FFPE Express (1)
Illumina HiSeq 2000 (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Top-down proteomics (1)

Instrument Platform

Q Exactive (9)
Illumina HiSeq 4000 (4)
DNBSEQ-G400 (3)
Illumina NovaSeq 6000 (3)
NextSeq 500 (3)
Gas Chromatography MS - positive (3)
Illumina HiSeq 2000 (2)
Liquid Chromatography MS - alternating - hilic (2)
Liquid Chromatography MS - negative - reverse-phase (2)
Liquid Chromatography MS - positive - reverse phase (2)
Liquid Chromatography MS - negative - hilic (2)
Genomics Core Shared Resources at Augusta University (RRID: SCR_026483) (1)
RNeasy Mini Kit (Qiagen) (1)
GentleMACS Octo Dissociator with Heaters (Miltenyi Biotec, Cat. No. 130-096-427) together with the Human Tumor Dissociation Kit (Miltenyi Biotec, Cat. No. 130-095-929), (1)
Instrument (1)
MicrOTOF-Q II (1)
Orbitrap Fusion (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2025 (144)
2026 (103)
2024 (102)
2023 (84)
2022 (73)
2015 (60)
2013 (50)
2019 (46)
2012 (44)
2018 (43)
2014 (43)
2016 (41)
2021 (39)
2020 (35)
2011 (35)
2017 (32)
2010 (19)
2009 (11)
2008 (10)
2007 (8)
2005 (4)
2006 (4)

CHEBI ID

CHEBI:57458 (1)
CHEBI:39074 (1)
CHEBI:8104 (1)
CHEBI:17289 (1)
CHEBI:137440 (1)
CHEBI:192376 (1)
CHEBI:33270 (1)
CHEBI:134538 (1)
CHEBI:75278 (1)
CHEBI:83063 (1)
CHEBI:61302 (1)
CHEBI:37480 (1)
CHEBI:74767 (1)
CHEBI:28223 (1)
CHEBI:33277 (1)
CHEBI:15245 (1)
CHEBI:195382 (1)
CHEBI:9637 (1)
CHEBI:62685 (1)
CHEBI:80603 (1)
CHEBI:1556 (1)
CHEBI:6909 (1)
CHEBI:28036 (1)
CHEBI:68567 (1)
CHEBI:8884 (1)
CHEBI:72733 (1)
CHEBI:165230 (1)
CHEBI:83501 (1)
CHEBI:133534 (1)
CHEBI:136638 (1)

Metabolite Name

LPC(18:0)+HCOO (1)
LPC(17:1)+HCOO (1)
LPC(17:0)+HCOO (1)
LPC(16:1e)+HCOO (1)
LPC(16:1)+HCOO (1)
LPC(16:0)+HCOO (1)
LPC(14:1e)+HCOO (1)
LPC(14:0)+HCOO (1)
Hex3Cer(d27:0)-H (1)
Hex2Cer(m44:0+O)+HCOO (1)
Hex2Cer(m40:4)-H (1)
Hex2Cer(m40:2)-H (1)
Hex2Cer(m38:2)-H (1)
Hex2Cer(m38:0+O)+HCOO (1)
Hex2Cer(m35:1)-H (1)
Hex2Cer(d44:2)+HCOO (1)
Hex2Cer(d44:1)+HCOO (1)
Hex2Cer(d42:3)+HCOO (1)
Hex2Cer(d18:1_24:1)-H (1)
Hex2Cer(d18:1_24:0)-H (1)
Hex2Cer(d42:1)-H (1)
Hex2Cer(d42:0)-H (1)
Hex2Cer(d41:2)+HCOO (1)
CL(17:1_16:1_18:1_16:1)-H (1)
Hex2Cer(d41:1)+HCOO (1)
Hex2Cer(d41:0)+HCOO (1)
Hex2Cer(d40:1)-H (1)
Hex2Cer(d40:0)+HCOO (1)
Hex2Cer(d39:1)+HCOO (1)
Hex2Cer(d38:1)+HCOO (1)

First Public Date

2024 (127)
2025 (120)
2026 (109)
2014 (92)
2023 (68)
2022 (56)
2019 (43)
2018 (40)
2020 (37)
2021 (34)
2015 (29)
2017 (28)
2016 (12)
2013 (5)

Study status

Not provided (3)
Recruiting (1)
Not yet recruiting (1)
Completed (1)

Lab affiliation

University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (5)
CEA-Marcoule, ProGenoMIX platform, DRF-Li2D, 30207 Bagnols-sur-Ceze, France (2)
Department of Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA (2)
School of Biomedical Sciences, University of Plymouth, UK (2)
Tumor Biology Moffitt Cancer Center Tampa, FL, USA (2)
1 - College of Pharmacy, University of Sharjah, Sharjah 2 - Sharjah Institute for Medical Research, University of Sharjah, Sharjah (1)
1INSERM, U1068, Cancer Research Center of Marseille, Institut Paoli-Calmettes, CNRS, UMR7258, and University Aix-Marseille, Marseille, France (1)
1Instituto de Ciências Biomédicas, Departamento de Parasitologia, Universidade de São Paulo, USP, São Paulo, Brazil. (1)
Analytical Chemistry Lab Fondazione Istituto Italiano di Tecnologia Via Morego 30, 16163 Genova Italy (1)
Associate Professor, Department of Pathology, Faculty of Medicine, The University of Hong Kong (1)
Baker Heart and Diabetes Inst. (1)
Bavarian Center for Biomolecular Mass Spectrometry (BayBioMS) School of Life Sciences Technical University Munich (TUM) Gregor-Mendel-Straße 4 85354 Freising GERMANY Bavarian Center for Biomolecular Mass Spectrometry Technische Universität München Gregor-Mendel-Straße 4 85354 Freising DEUTSCHLAND / GERMANY (1)
BioOrganic Mass Spectrometry laboratory (LSMBO) Institut Plurisciplinaire Hubert Curien University of Strasbourg. France (1)
Biozentrum, University of Basel, 4056 Basel, Switzerland (1)
Boston Univdrsity School of Medicine Department of hematology and oncology (1)
Boston University School of Medicine (1)
Brain Tumor Translational Targets B067 German Cancer Research Center (DKFZ) Im Neuenheimer Feld 580 69120 Heidelberg Germany Phone: +49 6221 42-4635 (1)
Brainstorm Brain Cancer Research, Brain and Mind Centre, University of Sydney, NSW, Australia School of Life and Environmental Science, University of Sydney, New South Wales, Australia (1)
CICS-UBI–Health Sciences Research Center, Universidade da Beira Interior, 6201-506 Covilhã, Portugal (1)
CMMB, University of South Florida (1)
CNRS, UMR7178, LSMBO, 67087 Strasbourg, FRANCE Université de Strasbourg, IPHC, 25 rue Becquerel, 67087 Strasbourg, FRANCE (1)
CRG, UPF (1)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (1)
Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University (1)
Centre de Recherche en Cancérologie de Marseille, Inserm UMR1068 Parc Scientifique et Technologique de Luminy 163, Avenue de Luminy Case 915 13288 Marseille Cedex 9 FRANCE (1)
Centre de recherche du Centre Hospitalier Universitaire (CHU) de Quebec-Université Laval, Québec, QC, Canada Centre de recherche sur le cancer de l’Université Laval, Québec, QC, Canada PROTEO-Quebec Network for Research on Protein Function, Engineering, and Applications, Québec, QC, Canada Department of Molecular Biology, Medical Biochemistry and Pathology, Université Laval, Québec, QC, Canada (1)
Chronic Disease Programme (UFIEC), Instituto de Salud Carlos III, Majadahonda, Madrid, Spain (1)
DIVAS University of Milan, Italy (1)
Department of Chemical Sciences, University of Naples “Federico II”, Naples, Italy CEINGE Advanced Biotechnologies, Naples, Italy (1)
Department of Chemistry, Chemical Biology Centre and State Key Laboratory of Synthetic Chemistry, The University of Hong Kong (1)

Keyword

Tissular factor (1)
TF (1)
FDG-PET-CT (1)
MRS, (1)
Colorectal cancer with histologically proven distant metastases (1)
CAR-T cell (1)
Minimal residue disease (1)
SENTINEL NODE (1)
DCE-MRI (1)
Health-related quality of life (1)
Metastases (1)
Liver (1)
Liver metastasis (1)
Colorectal (1)
DWI (1)

IsPrivate

False (1)

Classification

fungi (1)

Modification

4-tetrahydrothiazine-3-carboxylic acid (1)
Not available (1)

Study type

Transcription profiling by array (154)
RNA-seq of coding RNA (18)
Comparative genomic hybridization by array (12)
Methylation profiling by array (6)
ChIP-seq (5)
RNA-seq of non coding RNA (3)
Interventional (3)
Methylation profiling by high throughput sequencing (2)
Observational (2)
Unknown experiment type (1)
Differential (1)
Animal - One-color microarray (1)
RNAi profiling by array (1)
Transcription profiling by RT-PCR (1)
ATAC-seq (1)
MicroRNA profiling by array (1)
CUT&RUN (1)
RNA-seq of total RNA (1)
Observational patient registry (1)

Release Date

2022 (602)
2025 (584)
2021 (548)
2020 (523)
2023 (488)
2024 (454)
2019 (417)
2018 (338)
2017 (320)
2016 (320)
2015 (223)
2014 (181)
2013 (129)
2012 (108)
2011 (91)
2026 (85)
2010 (61)
2009 (44)
2008 (29)
2007 (14)
2006 (4)
2001 (4)
2005 (3)
2004 (3)
2003 (3)
2000 (2)
1998 (1)

Location

Netherlands (2)
Spain (1)
China (1)
France (1)

Previous page
1 / 724
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 724
Next page

Sort by:

Relevance

Page size

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease with distinct molecular subtypes described as classical/progenitor and basal-like/squamous PDAC. We hypothesized that integrative transcriptome and metabolome approaches can identify candidate genes whose inactivation contributes to ...

2024-04-02 | MTBLS9418 | MetaboLights

In vivo NCL-targeting affects breast cancer aggressiveness through miRNA regulation [Affymetrix]

Numerous studies have described the altered expression and the causal role of miRNAs in human cancer. However, to date efforts to modulate miRNA levels for therapeutic purposes have been challenging to implement. Here, we find that Nucleolin (NCL), a major nucleolar protein, post-transcriptionally r...

ORGANISM(S): Homo sapiens

2012-11-02 | E-GEOD-41972 | biostudies-arrayexpress

Transcription profiling of human breast cancers reveals bisphenol A induces a profile of tumor aggressiveness in high-risk cells of breast cancer patients

Breast cancer outcome is highly variable. Whether inadvertent exposure to environmental xenobiotics evokes a biological response promoting cancer aggressiveness and a higher probability of tumor recurrence remains unknown. To determine specific molecular alterations, which arise in high-risk breast ...

ORGANISM(S): Homo sapiens

2008-06-11 | E-GEOD-10270 | biostudies-arrayexpress

Unbalanced roles of fungal aggressiveness and host genetic background in the establishment of the Fusarium head blight in bread wheat

Fungal effectors are key determinants of disease development, promoting pathogen growth and spreading in plant tissues. In the wheat/Fusarium graminearum (Fg) interaction determining the Fusarium Head Blight disease (FHB), the molecular bases of Fg aggressiveness remain widely unknown. The aim of th...

ORGANISM(S): Fusarium graminearum Triticum aestivum (Wheat)

2020-01-13 | PXD015139 | Pride

Peripheral positioning of lysosomes supports melanoma aggressiveness

ORGANISM(S): Homo sapiens (Human)

2025-03-10 | PXD042007 | Pride

Exosomes

Peripheral positioning of lysosomes supports melanoma aggressiveness

PRJEB64554 | ENA

Leukemia aggressiveness is driven by chromatin remodeling and expression changes of core regulators [ChIP-seq]

PRJNA1177102 | ENA

Leukemia aggressiveness is driven by chromatin remodeling and expression changes of core regulators [RNA-seq]

PRJNA1177101 | ENA

In vivo NCL-targeting affects breast cancer aggressiveness through miRNA regulation

This SuperSeries is composed of the following subset Series: GSE41971: In vivo NCL-targeting affects breast cancer aggressiveness through miRNA regulation [NanoString] GSE41972: In vivo NCL-targeting affects breast cancer aggressiveness through miRNA regulation [Affymetrix] Refer to individual Serie...

ORGANISM(S): Homo sapiens

2012-11-02 | E-GEOD-41973 | biostudies-arrayexpress

Triangular Correlation (TrC) between cancer aggressiveness, cell uptake capability and cell deformability

PRJNA557700 | ENA

Previous page
1 / 724
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 724
Next page

Sort by:

Relevance

Page size

7234 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study status

Lab affiliation

Tags

Keyword

IsPrivate

Classification

Modification

Study type

Release Date

Location

OmicsDI is part of the ELIXIR infrastructure

Tweets